EJHaem

Keyphrases

Publications

volume 4, number 4, 2023

Frank G Keller, Brad Kahl, Jonathan W Friedberg
Current directions in the treatment of classical Hodgkin lymphoma. EJHaem 4 (4) (2023)
Luis Filgueira, Amir Steinberg, Rochelle Mendonca, Seah H Lim
Returning to employment following allogeneic hematopoietic stem cell transplant: A major problem among survivors. EJHaem 4 (4) (2023)
Naeem Desai, Jayne Peters, Elizabeth Davies, Joseph Sharif
The role of tocilizumab in the treatment of post-transfusion hyperhaemolysis. EJHaem 4 (4) (2023)
Afreen Jasim, Maria E Vergara-Lluri
Cryoglobulinemic vasculitis with blood schistocytosis and bone marrow vasculitis. EJHaem 4 (4) (2023)
Kaitlin Annunzio, Michael Ozga, Ying Huang, Mirela Anghelina, Seema A Bhat, James S Blachly, Michael R Grever, Gerard Lozanski, Jasmine Neal, Polina Shindiapina, Kerry A Rogers
Single-center study of outcomes of patients with hairy cell leukemia who contracted SARS-CoV-2. EJHaem 4 (4) (2023)
Joshua Richter, Darren Pan, Taylor Salinardi, Megan S Rice
Real-world multiple myeloma front-line treatment and outcomes by transplant in the United States. EJHaem 4 (4) (2023)
Jean Baptiste Rieu, Thibaut Jamme, Léonardo Astudillo, Lamisse Mansour-Hendili, Thierry Levade, Pierre Cougoul
Connecting the dots: Xanthoma, haemolytic anaemia, stomatocytosis and macrothrombocytopenia point to phytosterolaemia. EJHaem 4 (4) (2023)
Tite Minga Mikobi, Nelly Ciombo Kamuanya, Emmanuelle Ketsia Bokashanga Mikobi, Thérèse Ilunga Kalela, Pierre Zalagile Akilimali, Prosper Tshilobo Lukusa
Sickle cell anemia and pregnancy: Profile of hemodynamic changes in sickle cell pregnant women in Kinshasa. EJHaem 4 (4) (2023)
Graziana M Scigliuolo, Wahid Boukouaci, Barbara Cappelli, Fernanda Volt, Monica M Rivera Franco, Nathalie Dhédin, Regis Peffault de Latour, Christine Devalck, Jean-Hugues Dalle, Martin Castelle, Olivier Hermine, Marie Ouachée Chardin, Xavier Poiré, Bénédicte Brichard, Catherine Paillard, Hanadi Rafii, Chantal Kenzey, Ching-Lien Wu, Jihène Bouassida, Marie Robin, Nicole Raus, Vanderson Rocha, Annalisa Ruggeri, Eliane Gluckman, Ryad Tamouza, null null
HLA haplotype frequencies and diversity in patients with hemoglobinopathies. EJHaem 4 (4) (2023)
Carol Kwon, Christopher Gerard Mullen, Jennifer Buxton, Hadil AbuArqoub
Localised crystal-storing histiocytosis in a classical Hodgkin lymphoma patient post allogeneic transplant. EJHaem 4 (4) (2023)
Lai Yee Orbell, Nouf Abutheraa, Andrew S Duncombe, Mary Frances McMullin, Ruben A Mesa, Charlene M McShane, Glen James, Lesley Ann Anderson
The JAK2 V617F mutation and the role of therapeutic agents in alleviating myeloproliferative neoplasm symptom burden. EJHaem 4 (4) (2023)
Irene Biasoli, Nelson Castro, Carolina Colaço Villarim, Fabiola Traina, Carlos Sergio Chiattone, Monica Praxedes, Cristiana Solza, Leila Perobelli, Otavio Baiocchi, Rafael Gaiolla, Carla Boquimpani, Valeria Buccheri, Caroline Bonamin Sola, Roberta de Oliveira de Paula E Silva, Ana Carolina Ribas, Giovanna Steffenello, Katia Pagnano, Andrea Soares, Carmino de Souza, Nelson Spector
Treatment outcomes in classic Hodgkin lymphoma: 5-year update from the Brazilian Hodgkin Lymphoma Registry. EJHaem 4 (4) (2023)
Siba El Hussein, Kristen M O'Dywer, John M Bennett
Acute myelofibrosis superseding B-lymphoblastic leukemia/lymphoma. EJHaem 4 (4) (2023)
Bonaventure G Ikediashi, Cristina Ehrmann, Selma Gomez, Gisela Michel
Disease knowledge and health literacy in parents of children with sickle cell disease. EJHaem 4 (4) (2023)
Hiroki Kobayashi, Soichiro Okamoto, Mamoru Fujishima
Incidental detection of myeloid/lymphoid neoplasms with fibroblast growth factor receptor 1 rearrangement on fluorodeoxyglucose positron emission tomography. EJHaem 4 (4) (2023)
D Sorcini, A Stella, A Scialdone, S Sartori, A Marra, R Rossi, F De Falco, F M Adamo, E Dorillo, C Geraci, R Arcaleni, C Rompietti, A Esposito, L Moretti, M G Mameli, M P Martelli, Brunangelo Falini, Paolo Sportoletti
FLT3-targeted therapy restores GATA1 pathway function in NPM1/FLT3-ITD mutated acute myeloid leukaemia. EJHaem 4 (4) (2023)
Edwin Uriel Suárez, Sara Martín-Herrero, Francisco J Díaz de la Pinta
Bone lesions, chronic sinusitis, and perirenal involvement. EJHaem 4 (4) (2023)
Maoqin Li, Haihao Lu, Jiaoyang Fan, Min Dai, Chang Su
A nomogram prognostic model for diffuse large B-cell lymphoma based on SUVmax and GNRI in elderly patients. EJHaem 4 (4) (2023)
Nelson R Leung, Jennifer A Chapman, Sumeet Bhatia
First report of teclistamab in a patient with relapsed AL amyloidosis and multiple myeloma. EJHaem 4 (4) (2023)
Diogo Goulart Corrêa, Roberto Queiroz Dos Santos, Luiz Celso Hygino da Cruz
Contribution of intracranial vessel wall magnetic resonance imaging in nilotinib-associated vascular adverse effects diagnosis. EJHaem 4 (4) (2023)
Gaël Vermeersch, Timothy Devos, Helena Devos, Frédéric Lambert, Bruce Poppe, Sam Van Hecke
Germline heterozygous SH2B3-mutations and (idiopathic) erythrocytosis: Detection of a previously undescribed mutation. EJHaem 4 (4) (2023)
Andrew M Evens, Kara M Kelly
Lymphoma in adolescents and young adults: Navigating a path forward together. EJHaem 4 (4) (2023)
Paul Gerard Richardson, Thierry Facon, Christopher P Venner, Nizar J Bahlis, Fritz Offner, Darrell White, Lionel Karlin, Lotfi Benboubker, Eric Voog, Sung-Soo Yoon, Kenshi Suzuki, Hirohiko Shibayama, Xiaoquan Zhang, Miguel Villarreal, Philip Twumasi-Ankrah, Richard Labotka, Robert M Rifkin, Sagar Lonial, Shaji K Kumar, S Vincent Rajkumar, Philippe Moreau
Late versus early response and depth of response are associated with improved outcomes in patients with newly diagnosed multiple myeloma enrolled in the TOURMALINE-MM2 trial. EJHaem 4 (4) (2023)
Diana Beatriz S Bayani, Yihao Clement Lin, Melissa Gaik-Ming Ooi, Allison Ching Yee Tso, Hwee Lin Wee
Real-world utilization and healthcare costs for multiple myeloma: A retrospective analysis of patients in Singapore. EJHaem 4 (4) (2023)
Tatsuya Anzai, Naomi Nakashima, Hiroyuki Betsui, Yuta Kawahara, Yuriko Hayashi, Hirokazu Kimura, Akira Shimada
Infant case of severe immune thrombocytopenia caused by COVID-19 infection. EJHaem 4 (4) (2023)
Ivan Krečak, Marko Lucijanic
Duffy-null erythrocyte phenotype and the risk of thrombotic events in essential thrombocythemia. EJHaem 4 (4) (2023)
Christian Steidl, Robert Kridel, Michael S Binkley, Lindsay M Morton, Amy Chadburn
The pathobiology of select adolescent young adult lymphomas. EJHaem 4 (4) (2023)
Gedion Yilma Amdetsion, Aron Gudeta, Guy Lumley, Harkiran Sagoo, Ehab Aliledhin
Heparin-induced hyperkalemia, can LMWH cause hyperkalemia? A systematic review. EJHaem 4 (4) (2023)
Bao-Quan Song, Xin Kong, Yan Pu, Yin Liu, Jian Zhang, De-Pei Wu, Hui-Ying Qiu
Outcomes of venetoclax combined with homoharringtonine and cytarabine in fit adults patients with de novo adverse-risk acute myeloid leukaemia: A single-centre retrospective analysis. EJHaem 4 (4) (2023)
Sean Harrop, Phillip C Nguyen, David Byrne, Clarissa Wilson, Georgina L Ryland, Tamia Nguyen, Mary Ann Anderson, Seong Lin Khaw, Michelle Martin, Ing Soo Tiong, Elaine Sanij, Piers A Blombery
Persistence of UBTF tandem duplications in remission in acute myeloid leukaemia. EJHaem 4 (4) (2023)
Francesco Maura, Ragini M Adams, Tomohiro Aoki
Scientific techniques in adolescent and young adult classic Hodgkin lymphoma. EJHaem 4 (4) (2023)
Allison C Rosenthal, Adam S DuVall, Justine M Kahn, Niloufer Khan
Disparities in care and outcomes for adolescent and young adult lymphoma patients. EJHaem 4 (4) (2023)
Riley Plett, Craig Eling, Sarah Tehseen, Kathleen Felton, Gina Martin, Vivian Sheppard, Megan Pegg, Roona Sinha
Empowering patients with sickle cell anemia and their families through innovative educational methods. EJHaem 4 (4) (2023)
Nader Kim El-Mallawany, Lisa Giulino-Roth, John M Burke, Michelle Hermiston, Carl E Allen
Mature B-cell lymphomas in adolescents and young adults. EJHaem 4 (4) (2023)
Marc-Steffen Raab, Elena Zamagni, Salomon Manier, Paula Rodriguez-Otero, Schjesvold Fredrik, Annemiek Broijl
Difficult-to-treat patients with relapsed/refractory multiple myeloma: A review of clinical trial results. EJHaem 4 (4) (2023)
Heidi Loponen, Juha Mehtälä, Tero Ylisaukko-Oja, Oscar Brück, Kimmo Porkka, Perttu Koskenvesa, Kirsi Saukkonen, Juha Lievonen
Real-world experience of novel multiple myeloma treatments in a large, single-center cohort in Finland. EJHaem 4 (4) (2023)
Ezalia Esa, Ahmad Sabry Mohamad, Roszymah Hamzah, Faidatul Syazlin Abdul Hamid, Nur Aisyah Aziz, Veena Sevaratnam, Jameela Sathar, Guo Chen, Norafiza Mohd Yasin
Clinical and haematological characteristics of 38 individuals with Hb G-Makassar in Malaysia. EJHaem 4 (4) (2023)
Elena M Fenu, Tatyana Milman, Robert Penne, Farah El-Sharkawy Navarro, Guang Yang, Adam Bagg
Primary cutaneous T-follicular helper lymphoma. EJHaem 4 (4) (2023)
Keri Toner, Carl E Allen, Shweta Jain, Brad Kahl, John Leonard, Heather Wasserstrom, Jonathan W Friedberg, Nita L Seibel, Kara Kelly
Overcoming barriers to drug development and enrollment in clinical trials for adolescents and young adults with lymphoma. EJHaem 4 (4) (2023)
Ing Soo Tiong, William S Stevenson, Meaghan Wall, Yan Zhuang Yap, John F Seymour, Melita Kenealy, Piers A Blombery, null null
Favorable outcomes of DDX41 -mutated myelodysplastic syndrome and low blast count acute myeloid leukemia treated with azacitidine ± lenalidomide. EJHaem 4 (4) (2023)
Kosuke Obama, Hana Yamamoto, Hirosaka Inoue
Complete remission of aggressive Epstein-Barr virus-positive diffuse large B-cell lymphoma following withdrawal of tacrolimus and low-dose anticancer drugs. EJHaem 4 (4) (2023)
Hafiz A Ghani, Sri Bharathi Kavuri, Juan D Garcia, Christopher J Zahner, Kirill A Lyapichev
Metastatic cyclin D1 positive lobular breast carcinoma as a potential lymphoma mimicker. EJHaem 4 (4) (2023)
Pierre Peterlin, Marie C Béné, Maxime Jullien, Thierry Guillaume, Amandine Le Bourgeois, Alice Garnier, Camille Debord, Marion Eveillard, Patrice Chevallier
Assessment of monocytic-myeloid-derived suppressive cells (M-MDSC) before and after allogeneic hematopoietic stem cell transplantation in acute leukemia patients. EJHaem 4 (4) (2023)
Megan C Ramsey, Peter J B Sabatini, Adam C Smith, Ali Sakhdari
Molecular characterization and clonal evolution in Richter transformation: Insights from a case of plasmablastic lymphoma (RT-PBL) arising from chronic lymphocytic leukaemia (CLL) and review of the literature. EJHaem 4 (4) (2023)
Irene T Schrijver, Esta Kalikmanov-Mikhaylovskaya, Yorick Sandberg
Primary plasma cell leukaemia presenting as unilateral proptosis. EJHaem 4 (4) (2023)
Marta Ligero, Marc Simó, Cecilia Carpio, Gloria Iacoboni, Maria Balaguer-Montero, Victor Navarro, Mario Andres Sánchez-Salinas, Sabela Bobillo, Ana Marín-Niebla, Josu Iraola-Truchuelo, Pau Abrisqueta, Roser Sala-Llonch, Francesc Bosch, Raquel Perez-Lopez, Pere Barba
PET-based radiomics signature can predict durable responses to CAR T-cell therapy in patients with large B-cell lymphoma. EJHaem 4 (4) (2023)
Gabin Dubois, Emilie Virot, Manon Marie, Solène Poutrel, Giovanna Cannas, Arnaud Hot
Impact of COVID-19 on incidence, clinical presentation, and prognosis of acute chest syndrome in patients with sickle cell disease. EJHaem 4 (4) (2023)
Ernesto Pérez Persona, Laida Cuevas Palomares, Ariane Unamunzaga Cilaurren, Xabier Gutiérrez López de Ocáriz, Buenaventura Buendía Ureña, Ana Vega González de Viñaspre, Begoña Benito Ibarrondo, María Carmen Molinillo Fernández, Ana Cordero Osúa, Beatriz Benítez Delgado, Juan José García Albás, Miguel Ángel Andrés Moralejo, José María Guinea de Castro
Ultrafast 30-min infusion of a rituximab biosimilar (Truxima). EJHaem 4 (4) (2023)
Rocio Vila, Alba Rubio-San-Simón, Pablo Zubiaur, Marcos Navares-Gómez, Patricia Gómez-Hernández, Begoña Arce, Luis Madero
Use of glucarpidase (carboxypeptidase-G2) in pediatric cancer patients: 11-year experience of a tertiary center. EJHaem 4 (4) (2023)
Carmine Liberatore, Francesca Fioritoni, Annalisa Natale, Guido Montanaro, Gaetano La Barba, Cecilia Passeri, Ornella Iuliani, Bianca Fabi, Stefano Baldoni, Donatella Fantasia, Giuseppe Calabrese, Patrizia Accorsi, Stella Santarone, Stefano Pulini, Mauro Di Ianni
Daratumumab-based induction and autologous transplantation in concomitant multiple myeloma and chronic myeloid leukemia. EJHaem 4 (4) (2023)